TCL Archive CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely May 23, 2003
TCL Archive Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy October 30, 1998
TCL Archive NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research May 14, 1993
